Danaher Event
2023 Danaher Summit: Insights to Impact
11.07.23 EST
Washington, DC
United States
Keynote Addresses
Hear from some of the world’s most prominent voices in diagnostics and healthcare on the important roles diagnostics will play in the future of health, from empowering patient knowledge to making earlier cancer detection possible and addressing global antibiotic resistance.
Embracing Innovation in Public Health to Reimagine Preemptive Cancer Care
Stephen Hahn, MD
Dr. Hahn addresses the ambition to make early cancer detection as routine and accessible as a cholesterol test, through multi-cancer early detection (MCAD) screening. Timely, broad access is critical for early detection tools – as is rebuilding trust.
From Data to Diagnosis to Delivery: Artificial Intelligence in Precision Medicine
Atul Butte, Ph.D.
Dr. Butte rallies scientists and clinicians to harness an ever-growing reservoir of healthcare data that is already being used to empower patients, improve health equity, and inform clinical decision-making while reducing clinicians’ administrative burdens.
Too Little, Too Late
Lord Ara Darzi of Denham
Lord Darzi calls for a coordinated, decentralized approach to point-of-care diagnostics that considers scaled access and equity across whole populations.
Keynote Addresses: Q&A Sessions
Following each keynote address, the presenter sat down with a Danaher executive for a brief question and answer session.
Embracing Innovation in Public Health to Reimagine Preemptive Cancer Care Q&A
Stephen Hahn, MD
Moderated by Joakim Weidemanis, Executive Vice President, Danaher Corporation
From Data to Diagnosis to Delivery: Artificial Intelligence in Precision Medicine Q&A
Atul Butte, Ph.D.
Moderated by Joachim Reischl, Head of Innovation, Diagnostics and Precision Medicine, Danaher Corporation
Too Little, Too Late Q&A
Lord Ara Darzi of Denham
Moderated by Jose-Carlos Gutiérrez-Ramos, Chief Science Officer, Danaher Corporation
Panel Discussions
Dive into topic-focused discussions from experts across the diagnostics spectrum. Our panels featured engaging conversations on pressing issues including critical needs in patient advocacy, the changing role of diagnostics in medical education, defining hurdles to implementing the next generation of diagnostic tools and beyond.
The Access Odyssey: When Health Equity is Not Equal
Moderated by Sarah Kehoe, PhD
Panelists:
Loriana Hernandez-Aldama, ArmorUp for LIFE; Maimah Karmo, Tigerlily Foundation; Gary Puckrein, PhD, National Minority Quality Forum; Cecelia Schott, PharmD, MBA, Novartis
Hear from an interdisciplinary group discussing how basic access, education, trust, and social determinants of health play critical roles for patients and providers in making quality care and testing opportunities accessible to all patients.
Overcoming Big Data Chaos: Intelligent Integration of Complex Data for Patient Care, Are We Ready?
Moderated by Ephraim Tsalik, MD, PhD
Panelists:
Scott L. Friedman, MD, Icahn School of Medicine at Mount Sinai; Mara Aspinall, MBA, BlueStone Venture Partners; Kemi Badaki-Makun, MD, PhD, Johns Hopkins School of Medicine; Lincoln Nadauld, MD, PhD, Culmination Bio, Intermountain Precision Genomics
Over the past decade, revolutionary technologies have led to an unprecedented explosion of disease data. This panel explores how we can ensure providers have the resources to distill, use, and champion these complex data and diagnostic solutions in their quest for precision patient care.
Big Data, Bigger Dreams: Leveraging AI to Maximize Value-Based Care
Moderated by Akhil Saklecha, MD, MBA
Panelists:
Paul David Banick, MD, PhD, MBA, formerly United Healthcare, presently Dynamic Health Results, PLLC; Lee Fisher, MD, formerly Centers for Medicare and Medicaid Services; Jill Hagenkord, MD, FCAP, Optum Genomics; Adam Myers, MD MHCM FACHE CHCQM CPHRM
Value-based care strives to be a model for efficient and effective delivery of healthcare. This panel explores the role of evidence generation in diagnostic market access, including coding, coverage and reimbursement and the role of patient data and AI in optimizing value-based care and how it may help identify, predict, and manage patients more efficiently and effectively.
Constant Evolution: Implementing and Scaling Transformative Diagnostics Within the Healthcare System
Moderated by Anette Engelhardt
Panelists:
T. Clifford Deveny, MD, Summa Health; Bill Morice, MD, PhD, Mayo Collaborative Services, American Clinical Laboratory Association; Tom Vo, MD, MBA, Nutex Health; Michael Zinner, MD, Miami Cancer Institute
Hospital leaders are continually challenged with staying ahead of the ever-evolving healthcare landscape. This panel explores how hospital leaders can gain the confidence needed to leverage diagnostics as effective tools that aid in clinical decision making and improve health system performance.
When There Is Only One Way: Innovating a Healthier Future
Moderated by Vanessa Almendro, PhD, MBA
Panelists:
Andy Beck, MD, PhD, PathAI; Anthony Philippakis, MD, PhD, Broad Institute, Google Ventures; Shai Shen-Orr, PhD, Technion, CytoReason; David Walt, PhD, Harvard Medical School
Hear how different stakeholders can come together under new models to advance precision diagnostics. Whether through embracing complex new technologies or democratizing existing tests to patients via point-of-care solutions to maintain and restore health, there are countless opportunities to drive us from innovation to impact.
Lightning Presentations
How Danaher is Catalyzing Innovation
Danaher's Diagnostics businesses are catalyzing the future of diagnostics through collaborative R&D innovation. In the lightning presentations, our leaders showcase new platforms, modalities and approaches being developed to push the boundaries of what is possible in precision diagnostics.
From infectious disease and oncology to neurology and digital clinical decision support tools, hear how Beckman Coulter Diagnostics, Cepheid and Leica Biosystems are leading the way in researching and developing the cutting-edge tools needed most by labs and clinicians.
Transforming Emergency Care Using Artificial Intelligence
Jeremiah Hinson, MD, PhD, Beckman Coulter
Dr. Hinson discusses the use of TriageGo, a clinical decision support tool embedded in the electronic health record that supports triage nurses by applying artificial intelligence to emergency department assessments of severity.
Digital Pathology Comes of Age: Pathomics and Spatial Profiling
Rob Monroe, MD, PhD, Leica Biosystems
Dr. Monroe discusses the use of image-based innovative technologies such as digital pathology, spatial profiling, and high-flow imaging to advance oncology diagnostics.
Diagnostics for Neurodegenerative Disease
Zivjena Vucetic, MD, PhD, Beckman Coulter
Dr. Vucetic examines recent advances in high sensitivity immunoassay-based biomarker testing and emerging biomarker panels for the diagnosis and prognosis of neurodegenerative disease and neurocognitive disorders.
The Danaher Diagnostic Beacon for Sepsis Subtyping Innovation at Oxford University
Julian Knight, DPhil, Oxford; Jonathan Siegrist, PhD., Cepheid
Drs. Knight and Siegrist discuss an exciting new development in identifying different subtypes of sepsis – a pathological immune reaction that accounts for one out of every five deaths globally each year.